Researchers have estimated approximately 8% of Americas have ever experienced long COVID, or lasting symptoms, following an acute COVID-19 infection. Now two recent international studies suggest that the percentage is much higher among healthcare workers and dental professionals.
40% prevalence in health workers globally
In the first study, published in BMJ Public Health, authors conducted a meta-analysis of 28 studies with a combined sample size of 6,481 healthcare workers (HCWs). Globally, HCWs have been at an increased risk for COVID-19 infections since the beginning of the pandemic in 2020, due to both exposure to the virus and work conducted in a high-stress environment that may exacerbate the risk of long-term post-viral symptoms.
The authors defined long COVID as prolonged symptoms and/or functional disability following SARS-CoV-2 infection for at least 4 weeks from onset of symptoms or from time of diagnosis, in people when SARS-CoV-2 infection was self-reported, clinically diagnosed, and/or diagnosed through a laboratory test. All studies were conducted before February 2022.
During an average follow up of 22 weeks, the pooled prevalence of long COVID among HCWs who had SARS-CoV-2 infection was 40% (95% confidence interval [CI], 29% to 51%). In three studies with follow up after 12 months, pooled prevalence dropped to 26% (95% CI, 7% to 46%).
The most common symptoms reported by HCWs were fatigue (35%), neurologic symptoms (25%), loss/decrease of smell and/or taste (25%), muscle ache (22%), and shortness of breath (19%).
“Given the high prevalence of long COVID among HCWs, policymakers need to assess the impact of long COVID on the workforce in their areas and prioritize care for this condition,” the authors wrote. “Additionally, the findings suggest the need for tailored interventions to manage workloads and ensure adequate rest for HCWs affected by long COVID.”
Dental workers also at risk
In a second study, a survey conducted in Germany reveals a 23% rate of long COVID among dental professionals, with higher rates in auxiliary personnel than in dentists. The study is published in Scientific Reports.
The study was based on responses from 267 team members from 186 German dental practices who answered an online questionnaire on vaccination status, confirmed COVID-19 diagnosis, and self-reported long COVID symptoms.
A COVID-19 infection after January 1st, 2021, was reported by 146 (54.7%) participants, of which 33 (22.6%) suffered from long COVID symptoms, the authors said.
There were lower vaccination rates among dental auxiliary personnel compared to dentists (95.9% compared to 84.2%), and the auxiliary personnel (including assistants and hygienists) had higher rates of long COVID compared to dentists.
“Individuals with long COVID symptoms were more often dental assistants (long COVID 48.5% vs. no long COVID 29.2%) or dental hygienists (15.2% vs. 8.0%) than dentists (36.4% vs. 62.8%),” the authors wrote.
Similar to the first study, the most common long COIVD symptoms were exhaustion, fatigue, and lack of concentration. Overall, vaccination seemed to be protective against long COVID in this study.
We observed a 10% difference in the incidence of long COVID between vaccinated and non-vaccinated dental team members.
“We observed a 10% difference in the incidence of long COVID between vaccinated and non-vaccinated dental team members,” the authors wrote. “However, due to the small number of subjects with long COVID, we can not conclusively determine if unvaccinated dental healthcare personnel are more susceptible to suffer from long COVID or experience more severe symptoms.”
News
3D Human Brain Tissue Model Replicates Alzheimer’s Pathology
Summary: Researchers introduced a highly reproducible three-dimensional human brain tissue model capable of replicating complex neurodegenerative processes in Alzheimer’s disease. Developed over nine years using human stem cells, the self-organizing tissue spheroids integrate functional neurons, [...]
A Common Sugar May Loosen Cancer Cells and Help Them Spread
Chemotherapy may kill most ovarian cancer cells, but the few that survive can turn dangerously active. By releasing fructose, they may help nearby tumor cells break free and spread. Researchers at The Wistar Institute [...]
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]















